Insider Transactions in Q4 2020 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-81.36%
|
$870,000
$58.36 P/Share
|
|
Dec 31
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 31
2020
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
6,530
-43.25%
|
$378,740
$58.4 P/Share
|
|
Dec 31
2020
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,530
+31.22%
|
$45,710
$7.18 P/Share
|
|
Dec 30
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-94.33%
|
$885,000
$59.83 P/Share
|
|
Dec 30
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 30
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,520
-0.46%
|
$974,680
$59.43 P/Share
|
|
Dec 30
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,520
+0.91%
|
$0
$0.33 P/Share
|
|
Dec 29
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-73.46%
|
$900,000
$60.51 P/Share
|
|
Dec 29
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 29
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,790
-0.31%
|
$990,610
$59.67 P/Share
|
|
Dec 29
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,790
+0.93%
|
$0
$0.33 P/Share
|
|
Dec 28
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-77.72%
|
$930,000
$62.55 P/Share
|
|
Dec 28
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 28
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,250
-0.23%
|
$1,007,500
$62.05 P/Share
|
|
Dec 28
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+0.9%
|
$0
$0.33 P/Share
|
|
Dec 24
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-69.57%
|
$945,000
$63.89 P/Share
|
|
Dec 24
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 23
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-80.23%
|
$960,000
$64.63 P/Share
|
|
Dec 23
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 22
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
57,000
-60.85%
|
$3,591,000
$63.79 P/Share
|
|
Dec 22
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
57,000
+45.97%
|
$0
$0.84 P/Share
|
|
Dec 22
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-93.67%
|
$945,000
$63.99 P/Share
|
|
Dec 22
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 21
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
417
-100.0%
|
$24,603
$59.14 P/Share
|
|
Dec 21
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+50.0%
|
$2,502
$6.27 P/Share
|
|
Dec 21
2020
|
Michael J Pellini Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,500,000
$60.0 P/Share
|
|
Dec 21
2020
|
Michael J Pellini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$150,000
$6.55 P/Share
|
|
Dec 21
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-75.59%
|
$885,000
$59.44 P/Share
|
|
Dec 21
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 15
2020
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-93.98%
|
$112,000
$56.4 P/Share
|
|
Dec 15
2020
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Dec 15
2020
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-93.98%
|
$112,000
$56.39 P/Share
|
|
Dec 15
2020
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Dec 14
2020
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-61.16%
|
$348,000
$58.61 P/Share
|
|
Dec 14
2020
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$42,000
$7.8 P/Share
|
|
Dec 14
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
40,000
-80.0%
|
$2,360,000
$59.0 P/Share
|
|
Dec 14
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+44.44%
|
$0
$0.84 P/Share
|
|
Dec 14
2020
|
Viking Global Investors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-3.23%
|
$55,000,000
$55.65 P/Share
|
|
Dec 11
2020
|
Charles Sang SVP, External Affairs |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,800,000
$56.13 P/Share
|
|
Dec 11
2020
|
Charles Sang SVP, External Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$300,000
$6.55 P/Share
|
|
Dec 10
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,375,000
$55.0 P/Share
|
|
Dec 10
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.98 P/Share
|
|
Dec 08
2020
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-58.77%
|
$1,530,000
$51.75 P/Share
|
|
Dec 08
2020
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.18%
|
$180,000
$6.32 P/Share
|
|
Dec 07
2020
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,250
-55.77%
|
$312,500
$50.06 P/Share
|
|
Dec 07
2020
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$43,750
$7.8 P/Share
|
|
Dec 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
6,770
-72.73%
|
$324,960
$48.82 P/Share
|
|
Dec 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+34.03%
|
$40,620
$6.79 P/Share
|
|
Nov 23
2020
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,880
-34.64%
|
$132,480
$46.0 P/Share
|